Clinical Trials Browser

Phase 3 × PT-100 dipeptide × Thoracic × Clear all

NCT00243204 2007-06-08

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms